Two occasional HCR bloggers are co-authors of an article published this week:
Why the NIH Trial to Assess Chelation Therapy (TACT) Should Be Abandoned
Kimball C.
Atwood IV, MD; Elizabeth Woeckner, AB, MA; Robert S. Baratz, MD, DDS, PhD; Wallace I. Sampson, MD
Medscape J Med. 2008;10(5):115.
©2008 Medscape
Posted 05/13/2008
Abstract:
The National Institutes of Health (NIH) Trial to Assess Chelation Therapy (TACT) was begun in 2003 and is expected to be...
New 'real-world' reassuring data from the SCAAR...
(European Society of Cardiology) A registry -which includes every patient in Sweden having percutaneous coronary intervention for the treatment of acute and stable coronary artery disease-...
Many With Coronary Artery Disease Not on Statins...
(MedPage Today) -- Despite evidence from clinical trials that statins help prevent cardiovascular events, many patients with obstructive coronary artery disease are not being treated with the...
New CABG, PCI Guidelines Stress Collaboration (CME/CE)
(MedPage Today) -- New guidelines, the result of a first-time collaboration between the American College of Cardiology and the American Heart Association, stress a multidisciplinary approach...
Country Save HE Laundry Detergent, Powder, 160-Load,...
Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...
Post new comment